• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/24 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulfur atoms by sulfur atoms to which a second hetero atom is attached

Patent holdings for IPC class C07D 211/24

Total number of patents in this class: 75

10-year publication summary

4
4
7
4
7
6
7
2
4
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Prilenia Neurotherapeutics Ltd.
89
16
Takeda Pharmaceutical Company Limited
2696
5
Teva Pharmaceuticals International GmbH
319
4
Teva Pharmaceuticals USA, Inc.
893
4
Novartis AG
10829
3
Epizyme, Inc.
373
3
Generation Bio Co.
149
3
Agency for Science, Technology and Research
3627
2
IVAX International GmbH
6
2
National University of Singapore
2453
2
AstraZeneca AB
2900
1
AstraZeneca UK Limited
638
1
Boehringer Ingelheim International GmbH
4644
1
Syngenta Crop Protection AG
6067
1
Abbott Laboratories
2405
1
Bayer Pharma AG
1047
1
Abbott GmbH & Co. KG
127
1
The Board of Trustees of Illinois State University
22
1
Cognition Therapeutics, Inc.
39
1
Faes Farma, S.A.
106
1
Other owners 21